期刊文献+

低毫安的电化学疗法对人乳腺癌MCF-7细胞的细胞周期及c-myc和cyclin E蛋白表达的影响 被引量:4

Effect of Electrochemical Therapy with Low Milli-Ampere on Cell Cycle and Expression of c-myc and Cyclin E in Human Breast Cancer Cell Line MCF-7
下载PDF
导出
摘要 目的探讨低毫安(10 m1A)的电化学治疗对体外人乳腺癌MCF-7细胞的细胞周期分布及c-myc和cyclin E表达的影响。方法电化学治疗后培养6h和24h的细胞用MTT法、流式细胞术、免疫组化法测定细胞抑制率、细胞周期分布及细胞c-myc和cyclin E蛋白的表达。结果与对照组相比,治疗组人乳腺癌MCF-7细胞抑制率均随电量增加依次增高(P<0.05);治疗组随电量的增加处于G0/G1期的比例逐渐增高,而S期细胞比例逐渐下降(P<0.05),G2/M期变化不明显(P>0.05);治疗组c-myc和cyclin E表达随电量的增加阳性细胞数逐渐减少。电化学治疗后培养24h比6h各组指标变化显著。结论电化学治疗能通过调节人乳腺癌MCF-7细胞c-myc和cyclin E蛋白的表达,促使细胞G0/G1期阻滞,从而抑制细胞生长。 Objective To explore the effect of electrochemical therapy with low milli - Ampere( 10 mA) on cell cycle and expression of c - mye and cyclin E in human breast cancer cell line MCF - 7. Methods Equal number of breast cancer cells were treated by the electrochemical treatment, the changes of cell proliferation, cell cycle distribution, c - myc and cyclin E protein expression of MCF - 7 cells were observed by MTY test, flow cytometry and Immunohistochemistry Methods. Results The inhibitory rate was significantly increased after 6h and 24h of ECT tratment compared with the controls(P 〈0.05). The proportion of G0/G~ phase cells treated with different electrochemical treatment doses in vitro was higher than that in the control group (P 〈 0. 05 ), but the proport ion of S cells was lower than that in the control group ( P 〈 0.05 ). The expres- sion o f c - myc and cyclin E protein decreased. Conclusion The study showed that the ECT displayed po- tent antiproliferative activity towards cancer cells through suppressing cell cycle proteins, arresting cell cycle at G0/G1 phase.
出处 《宁夏医科大学学报》 2012年第2期106-109,F0002,共5页 Journal of Ningxia Medical University
基金 宁夏自然科学基金项目(NZ09164)
关键词 电化学疗法 人乳腺癌细胞株MCF-7 C-MYC cyclin E 细胞周期 electrochemical therapy human breast cancer cell line MCF - 7 c - myc cyclin E cell cycle
  • 相关文献

参考文献8

  • 1张玮,黎丹戎,唐步坚,蒋志峰,李力.电化学治疗对宫颈癌细胞系细胞周期及CDK、cyclin表达的影响[J].现代妇产科进展,2010,19(7):502-505. 被引量:10
  • 2Colombo L,Gonzdlez G,Marshall G,et al.Ion transport in tumors under electrochemical treatment:in vivo,in vitro and in silico modeling[J].Bioelectrochemistry,2007,71(2):223-232.
  • 3Tang BJ,Li L,Jiang Z,et al.Characterization of the mechansms of electro-chemotherapy in an in vitro model for human cervical cancer[J].J Oncol,2005,26:703-711.
  • 4C larke B,chetty K.Cell aberrations in the pathogenesis of squamous cell carcinoma of the uterin cervix[J].Gynecol Oncol,2001,82:238-246.
  • 5Santoni-Rugiu E,Falck J,Mailand N,et al.Involvement of myc activity in a G1/S-promoting mechanism parallel to the pRb/E2F pathway[J].Mol Cell Biol,2000,20(10):3497-3509.
  • 6Loden M,Stighall M and Nielsen NH,et al.The cyclin D1 high and cyclin E high subgroups of breast cancer:separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node[J].Oncogene,2002,21:4680-4690.
  • 7Jason S,Carroll,Alexander Swarbrick and Elizabeth A,et al.Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells:implications for the antiproliferative effects of antiestrogens[J].Cancer Res,2002,62:3126-3313.
  • 8陈艳华,黎丹戎,朱波,蒋志峰.直流电治疗诱导宫颈癌HELA细胞凋亡与外环境离子浓度变化关系的研究[J].中国现代医学杂志,2006,16(3):371-374. 被引量:3

二级参考文献22

  • 1唐步坚,李力,赵恒毅,古明华,陈心秋,黄玲莎,唐东平.电化学对人宫颈癌细胞系Hela-S生物学作用的实验研究[J].肿瘤防治研究,1997,24(1):4-7. 被引量:7
  • 2TANG B, LI L, JIANG Z, et al. Characterization of the mechanisms of electrochemotherapy in an in vitro model for human cervical cancer[J]. Int J Oncol, 2005, 26(3): 703-711.
  • 3NORDERSTROM BEW. Survey of mechanism in elechochemical treatment of cancer[J]. Eur J Surg, 1994, 574(Suppl): 93-96.
  • 4KERR JER. WINTERFORD CM, BIOL ADA, et al. Apoptosis:its significance in cancer therapy Cancer, 1994, 73: 2013-2019.
  • 5MIR LM, ORLOWSKI S. Mechanisms of electrochemotherapy[J].Adv Drug Deliv Rev, 1999, 35(1): 107-118.
  • 6BRANDISKY K, DASKALOV I. Electrical field and current distributions in electrochemotherapy [J]. Bioelectrochem Biaenerg,1999, 48(1): 201-208.
  • 7VERMES I, HAANEN C, STEFFENS-NAKKEN H, et al. A novel, assay for apoptosis-flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V[J]. J Immunol Meth, 1995, 184: 39.
  • 8ZUI P, MANJUNATHA B. BHAT, ANNA-LIISA NIEMINEN, et al. Synergistic Movements of Ca^2+ and Bax in Cells Undergoing Apoptosis[J]. J. Biol. Chem, 2001, 276: 32257□32263.
  • 9Halehison C, Glover DM. Cell cycle control[M ]. Oxford: IRL Press, 1995.
  • 10Tang B J, Li L, Jiang Z,et al. Characterization of the mechanisms of electro-chemotherapy in an in vitro model for human cervical cancer [ J ]. J Oncol, 2005,26 : 703-711.

共引文献11

同被引文献25

  • 1Amiri-Kordestani L,Basseville A,Kurdziel K,et al.Targeting MDR in breast and lung cancer:discriminating its potential importance from the failure of drug resistance reversal studies[J].Drug Resist Updat,2012,15 (1-2):50-61.
  • 2Shawki MM,Elblbesy MA,Shalaby TE,et al.Comparative study on the efficiency of using pulsed and direct current electrochemotherapy in treating ehrlich tumor[J].Int J Biomed Sci,2012,8 (1):16-21.
  • 3Campana LG,Mocellin S,Basso M,et al.Bleomycin-based electrochemotherapy:clinical outcome from a single institution's experience with 52 patients[J].Ann Surg Oncol,2009,16(1):191-199.
  • 4Larkin JO,Collins CG,Aarons S,et al.Electrochemotherapy:aspects of preclinical development and early clinical experience[J].Ann Surg,2007,245 (3):469-479.
  • 5Tang B J,Li L,Jiang Z,et al.Characterization of the mechanisms of electro-chemotherapy in an in vitro model for human cervical cancer[J].J Oncol,2005,26:703-711.
  • 6Campana LG, Mocellin S, Basso M, et al. Bleomycin-based electroche- motherapy: clinical outcome from a single institution' s experience with 52 patients[J]. Ann Surg Onco1,2009,16( 1 ) :191-199.
  • 7Larkin JO, Collins CG, Aarons S, et al. Electrochemotherapy : aspects of preclinical development and early clinical experience [ J ]. Ann Surg, 2007,245 (3) :469-479.
  • 8Tang B, Li L, Jiang Z,et al. Characterization of the mechanisms of e-lectro-chemotherapy in an in vitro model for human cervical cancer [ J ]. Int J Onco1,2005,26 (3) :703-711.
  • 9He S, Liu F, Xie Z, et al. P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer ceils [J]. Int J Mol Sci,2010,11(9) :3309-3351.
  • 10Doublier S, Belisario DC, Polimeni M, et al. HIF-1 activation induces doxorubicin resistance in MCF-7 3-D spheroids via P-glycoprotein ex- pression:a potential model of the chemo-resistance of invasive micro- papillary carcinoma of the breast [ J ]. BMC Cancer,2012,12:4.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部